These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 9346177

  • 1. Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors.
    Tateyama H, Eimoto T, Tada T, Inagaki H, Hattori H, Takino H.
    Mod Pathol; 1997 Oct; 10(10):983-91. PubMed ID: 9346177
    [Abstract] [Full Text] [Related]

  • 2. Proliferative activity and apoptosis in thymic epithelial neoplasms.
    Hiroshima K, Iyoda A, Toyozaki T, Supriatna Y, Shibuya K, Shimamura F, Haga Y, Yoshida S, Fujisawa T, Ohwada H.
    Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma.
    Dorfman DM, Shahsafaei A, Miyauchi A.
    Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of Bcl-2 protein in the myasthenic thymus.
    Onodera J, Nakamura S, Nagano I, tobita M, Yoshioka M, Takeda A, Oouchi M, Itoyama Y.
    Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of prognostic features in thymic epithelial tumors.
    Kirchner T, Schalke B, Marx A, Müller-Hermelink HK.
    Thymus; 1989 Apr; 14(1-3):195-203. PubMed ID: 2623740
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical localization of Mcl-1 and bcl-2 proteins in thymic epithelial tumours.
    Chen FF, Yan JJ, Chang KC, Lai WW, Chen RM, Jin YT.
    Histopathology; 1996 Dec; 29(6):541-7. PubMed ID: 8971561
    [Abstract] [Full Text] [Related]

  • 7. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.
    Pan CC, Chen PC, Wang LS, Lee JY, Chiang H.
    Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732
    [Abstract] [Full Text] [Related]

  • 8. Expression of apoptosis-related antigens, Fas, bcl-2, and p53, and Mib-1 proliferation index in the hypoplastic thymus of DiGeorge syndrome.
    Zhou H, Perkins SL, Tripp S, Hussong JW, Coffin CM.
    Pediatr Dev Pathol; 2002 Aug; 5(5):465-71. PubMed ID: 12202998
    [Abstract] [Full Text] [Related]

  • 9. An immunohistochemical study of thymic epithelial tumors. III. The distribution of interdigitating reticulum cells and S-100 beta-positive small lymphocytes.
    Kondo K, Mukai K, Sato Y, Matsuno Y, Shimosato Y, Monden Y.
    Am J Surg Pathol; 1990 Dec; 14(12):1139-47. PubMed ID: 2252104
    [Abstract] [Full Text] [Related]

  • 10. Thymoma. Histologic subclassification is an independent prognostic factor.
    Quintanilla-Martinez L, Wilkins EW, Choi N, Efird J, Hug E, Harris NL.
    Cancer; 1994 Jul 15; 74(2):606-17. PubMed ID: 8033040
    [Abstract] [Full Text] [Related]

  • 11. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
    Suzuki E, Sasaki H, Kawano O, Endo K, Haneda H, Yukiue H, Kobayashi Y, Yano M, Fujii Y.
    Jpn J Clin Oncol; 2006 Jun 15; 36(6):351-6. PubMed ID: 16762968
    [Abstract] [Full Text] [Related]

  • 12. PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Müller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification.
    Hattori H, Tateyama H, Tada T, Saito Y, Yamakawa Y, Eimoto T.
    Virchows Arch; 2000 Jan 15; 436(1):20-7. PubMed ID: 10664158
    [Abstract] [Full Text] [Related]

  • 13. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
    Yoh K, Nishiwaki Y, Ishii G, Goto K, Kubota K, Ohmatsu H, Niho S, Nagai K, Saijo N.
    Lung Cancer; 2008 Dec 15; 62(3):316-20. PubMed ID: 18448188
    [Abstract] [Full Text] [Related]

  • 14. Expression of proteasome subunit β5t in thymic epithelial tumors.
    Yamada Y, Tomaru U, Ishizu A, Kiuchi T, Marukawa K, Matsuno Y, Kasahara M.
    Am J Surg Pathol; 2011 Sep 15; 35(9):1296-304. PubMed ID: 21836487
    [Abstract] [Full Text] [Related]

  • 15. [The level of Bcl-2 and Fas expression in thymoma tissue from patients with myasthenia gravis].
    Shen G, Chai Y, Yue L, Wei HQ, Lin M.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Apr 15; 29(4):240-2. PubMed ID: 16750039
    [Abstract] [Full Text] [Related]

  • 16. Thymomas and thymic carcinomas. Evaluation of the Müller-Hermelink classification.
    Papla B, Rudnicka L, Dubiel-Bigaj M, Malinowski E.
    Pol J Pathol; 1998 Apr 15; 49(4):251-65. PubMed ID: 10323079
    [Abstract] [Full Text] [Related]

  • 17. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M, Umezu H, Hashimoto T, Shinohara H, Koike T, Hosaka Y, Eimoto T, Hayashi JI.
    Lung Cancer; 2008 Dec 15; 62(3):321-5. PubMed ID: 18486988
    [Abstract] [Full Text] [Related]

  • 18. Expression of neurotrophin receptors in surgically resected thymic epithelial tumors.
    Kim DJ, Yang WI, Kim SH, Park IK, Chung KY.
    Eur J Cardiothorac Surg; 2005 Oct 15; 28(4):611-6. PubMed ID: 16125946
    [Abstract] [Full Text] [Related]

  • 19. L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.
    Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.
    J Surg Oncol; 2009 Jun 01; 99(7):433-8. PubMed ID: 19347882
    [Abstract] [Full Text] [Related]

  • 20. Thymomas and thymic carcinomas. A retrospective investigation with histological reclassification.
    Engel P, Pilsgaard B, Francis D.
    APMIS; 1995 Sep 01; 103(9):671-8. PubMed ID: 7488389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.